Curtis Lachowiez

22PUBLICATIONS
160CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMusic therapyPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 28, 2026
OPTI-AML: Prospective Comparison of 28 vs.14 days of Venetoclax Induction with Azacitidine in Older Adults with AML.

|Jul 02, 2026
Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

|Jun 05, 2026
HMA+VEN triplet regimens for the initial treatment of AML in adults (PRO).

|Mar 31, 2026
Models, Models, Everywhere: But Which One Should Guide Care?

Curtis A Lachowiez, Sanam Loghavi

|Nov 05, 2025
Rapid clonal selection within early hematopoietic cell compartments presages the outcome of ivosidenib combination therapy.

Sven Turkalj, Felix A Radtke, Bilyana Stoilova

|Oct 20, 2025
Olutasidenib: an Achilles' heel for IDH1-mutated MDS?

Laura Wiser, Curtis Lachowiez

Pageof 4

Frequent Collaborators

10 joint publications

Courtney D DiNardo

10 joint publications

Sanam Loghavi

8 joint publications

Naval G Daver

6 joint publications

Tapan M Kadia